Rucaparib, sold under the brand name Rubraca, is a PARP inhibitor used as an anti-cancer agent. it is an anti-cancer agent used to treat recurrent ovarian, fallopian tube, or peritoneal cancer. Reference standards of Rucaparib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Rucaparib
Catalogue No.:PA 18 1210000
CAS :
Molecular Formula : C19H18FN3O
Molecular Weight : 323.37
8-Fluoro-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one
Catalogue No.:PA 18 1211000
Molecular Formula : C11H9FN2O
Molecular Weight : 204.2
Methyl (E)-6-fluoro-3-(2-nitrovinyl)-1H-indole-4-carboxylate
Catalogue No.:PA 18 1211001
Molecular Formula : C12H9FN2O4
Molecular Weight : 264.21
Methyl 6-fluoro-3-(2-nitroethyl)-1H-indole-4-carboxylate
Catalogue No.:PA 18 1211002
Molecular Formula : C12H11FN2O4
Molecular Weight : 266.23
Methyl 6-fluoro-1H-indole-4-carboxylate
Catalogue No.:PA 18 1211003
Molecular Formula : C10H8FNO2
Molecular Weight : 193.18
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
